; published online 15 January 2010
Sir, Eyelid necrosis after local anaesthesia for lacrimal sac surgery A 74-year-old woman (C1) and an 81-year-old woman (C2) with no history of atopy each received a standard injection of 3 ml lidocaine hydrochloride 2% and 1/100 000-epinephrine into the medial canthal region in preparation for dacryocystectomy. For each injection, the contents were obtained from a recently opened sterile bottle and delivered with a single sterile needle. Each woman had received lidocaine local anaesthesia (LLA) in the past, peribulbar administration in the case of C1 and nonophthalmic administration for the implantation of a pacemaker in C2. During the injection, each of them experienced sudden faintness and local pain, and within a few hours, an extensive periorbital erythema and swelling was observed. Within 8 days, skin necrosis involving the medial canthus occurred and was accompanied by a serous fluid-filled bulla (Figures 1a and 2a ). There was no sign of periorbital/orbital involvement on computerised tomography, no abnormal laboratory findings, and microorganisms were absent in direct microscopy and in the culture of bullous fluid. Treatment with intravenous amoxicillin and local and systemic corticosteroids was given. After 15 days, swelling and necrotic skin changes decreased (Figures 1b and 2b) , and 6 months later, a retractile pigmented scar with a lower lid cicatricial ectropion (Figures 1c, d and 2c ) was noted.
In ophthalmic surgery, side effects of LLA are uncommon, but they have been reported after subconjunctival injection or retrobulbar anaesthesia.
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Inadvertent intravascular injection, leading to platelet-fibrin emboli or vasoconstriction by epinephrine, resulting in occlusion of the lacrimal artery, is also reported.
3,4 Among the amide anaesthetics, lidocaine shows a higher toxicity to the central nervous and cardiovascular systems; prilocaine produces less vasodilatation and toxicity but causes methaemoglobin formation.
1 In the case of these two women, there was no evidence of peripheral vascular disease or diabetes, but there had been previous exposure to lidocaine. We hypothesise that an immediate type IV hypersensitivity reaction to lidocaine occurred in these patients.
3,5 It may be impractical to avoid the repeated use of LLA in patients undergoing multiple surgeries, and in any case, a cross reaction between these two main classes of anaesthetic drugs may still occur.
5 What is important is to recognise the possibility of this complication, advise patients accordingly, and have corticosteroids on hand to limit the severity of the inflammatory reaction and ameliorate the progression of necrosis, should it appear. 
